Mergers and Acquisitions TRANSACTIONAL

WilmerHale lawyers have decades of experience advising public and private companies in all aspects of mergers and acquisitions in both the United States and Europe.


Market leaders in life sciences, technology, financial services, communications and many other industries turn to WilmerHale for legal advice and business advantage. In 2015, we advised clients throughout the United States and Europe on more than 75 M&A transactions providing guidance in areas including corporate, securities, antitrust and tax. Since 2004, we have participated in more than 1,200 mergers and acquisitions with a total value in excess of $500 billion, ranging from sales of VC-backed companies to multibillion-dollar global mergers. Our experience ranges from public-public M&A transactions and the related disclosure and fiduciary duty issues to the unique issues presented by acquisitions of financial sponsor-backed private companies. We also advise clients on hostile transactions and activist investors, and represent investment banks serving as financial advisors in M&A transactions. 

Contacts

Sort By
Bothwick, Jay E.

Jay E. Bothwick

Co-Chair, Mergers and Acquisitions Practice Group

+1 617 526 6526 (t)

jay.bothwick@wilmerhale.com

Leibowitz, Hal J.

Hal J. Leibowitz

Co-Chair, Mergers and Acquisitions Practice Group

+1 617 526 6461 (t)

hal.leibowitz@wilmerhale.com

Bain, Mick

Mick Bain

Partner

+1 617 526 6158 (t)

michael.bain@wilmerhale.com

Boot, Jeannette K.

Jeannette K. Boot

Partner

+1 212 295 6507 (t)

jeannette.boot@wilmerhale.com

Borden, Mark G.

Mark G. Borden

Partner

+1 617 526 6675 (t)

mark.borden@wilmerhale.com

Bothwick, Jay E.

Jay E. Bothwick

Partner

+1 617 526 6526 (t)

jay.bothwick@wilmerhale.com

Braun, Martin

Dr. Martin Braun

Partner

+49 69 27 10 78 207 (t)

martin.braun@wilmerhale.com

Brown, Lillian

Lillian Brown

Partner

+1 202 663 6743 (t)

lillian.brown@wilmerhale.com

Buckland, Peter

Peter Buckland

Partner

+1 650 858 6036 (t)

peter.buckland@wilmerhale.com

Coates, Sam

Samuel S. Coates

Partner

+1 650 858 6000 (t)

samuel.coates@wilmerhale.com

Experience

Representative experience includes:

  • Akamai Technologies' acquisitions of Prolexic Technologies for $403 million and Codemate for $107.5 million;
  • Analog Devices' acquisition of Hittite Microwave for $2.5 billion;
  • Booz Allen Hamilton's acquisition of the Defense Systems Engineering & Support division of ARINC for $154 million;
  • DirectEdge's acquisition by BATS Global Markets (undisclosed purchase price);
  • Durata Therapeutics' acquisition by Actavis for $760 million;
  • Gilt Groupe Holdings' acquisition by Hudson's Bay Company for $250 million;
  • LoopPay's acquisition by Samsung (undisclosed);
  • Palomar Medical Technologies' acquisition by Cynosure for $294 million;
  • Progress Software's acquisition of Telerik for $262.5 million;
  • Sanbolic's acquisition by Citrix Systems for $89.6 million;
  • Staples' acquisition of Office Depot for $6.3 billion (pending);
  • The Medicines Company's acquisition of Rempex Pharmaceuticals for $474 million (including milestone payments), and in the sale of global portfolio of hemostasis products to Mallinckrodt for $410 million;
  • Thermo Fisher Scientific's sale of its cell culture, gene modulation and magnetic beads businesses to GE Healthcare for $1.06 billion;
  • TEI Biosciences' acquisition by Integra Life Sciences for $312 million; and
  • WEX's acquisition of Electronic Funds Source for $1.4 billion (pending).

Additional M&A experience: 2016, 20152014, 20132012, 2011, 2010, 2009

Publications & News

View

May 3, 2016

Selected 2016 Life Sciences Transactions

Recognized both globally and nationally for its leading life sciences practice, WilmerHale has more than four decades of experience representing biotechnology, pharmaceutical and medical device companies at all stages of growth, as well as venture capitalists and investment banks.

May 3, 2016

WilmerHale Represents MKS Instruments in Acquiring Newport Corporation and Securing $980 Million Acquisition Financing

WilmerHale represented its long-time client MKS Instruments, Inc., a global technology provider, in closing its acquisition of Newport Corporation, a worldwide leader in photonics solutions, for approximately $905 million.

May 2, 2016

WilmerHale Expands West Coast Corporate Practice With Two Partner Hires

WilmerHale is pleased to welcome Partners Christopher Rose and Eric Hwang to the firm's Los Angeles and Palo Alto offices, respectively.

March 29, 2016

WilmerHale Reps Micro Focus in $540M Acquisition of Serena Software

On March 22, 2016, Micro Focus announced its intent to acquire Serena Software, Inc., a leading provider of Application Lifecycle Management software, in a transaction valued at $540 million.

March 27, 2016

WilmerHale Lawyers and Practices Recognized in 2016 Edition of Chambers USA

Chambers USA: America's Leading Lawyers for Business announced its final rankings for the 2016 edition, with WilmerHale ranking among the nation's best in 47 practice area categories. Chambers also ranked 82 WilmerHale lawyers as leaders in their respective fields.

March 24, 2016

2016 Corporate Reports

WilmerHale's annual IPO, Venture Capital and M&A Reports offer insights into market conditions and provide comprehensive statistics and analysis that are hard to find elsewhere.

March 24, 2016

2016 M&A Report

Our 2016 M&A Report offers a detailed review of, and outlook for, the global M&A market. Other highlights include a comparison of deal terms in public and private acquisitions; updates on takeover defenses and public company deal litigation; practical guidance on avoiding antitrust violations in pre-merger integration planning; a look at what buyers need to know about appraisal claims in private company mergers; and a survey of key terms and issues in sales of VC-backed companies.

March 14, 2016

M&A: The Last Refuge For Biotechs Seeking Funding

WilmerHale's Life Sciences Group Co-Chairs Belinda Juran and Stuart Falber are interviewed by MedCity News—published by Breaking Media which, earlier this year, ranked the firm among the top three Best Life Sciences Law Firms for 2016 in its inaugural Life Science Index.

February 29, 2016

After In re Trulia: Increased Scrutiny for the Give and the Get in Disclosure Settlements

Early in the deal process, companies should seek advice on how best to reduce the risk of deal litigation and, if it arises, how best to navigate the realities of deal litigation during these changing times.

February 25, 2016

Energy Sector Alert Series: Five Essentials for Managing Deal Risk

Oil prices have fallen below $30 per barrel for the first time in more than a decade. This trend, along with the shale gas boom, evolving regulatory constraints, and a growing focus on renewables, have made one thing clear: the oil and gas industry is getting a makeover.